标题
The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies
作者
关键词
-
出版物
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-20
DOI
10.1007/s12016-021-08898-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regulation of the Migration of Distinct Dendritic Cell Subsets
- (2021) Meng Feng et al. Frontiers in Cell and Developmental Biology
- Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology
- (2020) Jasper C. A. Broen et al. Nature Reviews Rheumatology
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Meta-analysis on the efficacy and safety of immunoadsorption for systemic lupus erythematosus among Chinese population
- (2020) Meng Yang et al. CLINICAL RHEUMATOLOGY
- Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus
- (2020) Mariele Gatto et al. Arthritis & Rheumatology
- Systemic lupus erythematosus (SLE): emerging therapeutic targets.
- (2020) Lauren M Mathias et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- TWEAK/Fn14 axis is an important player in fibrosis
- (2020) Yitian Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-like receptor signalling in B cells during systemic lupus erythematosus
- (2020) Simon Fillatreau et al. Nature Reviews Rheumatology
- The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
- (2020) Marcello Govoni et al. RHEUMATOLOGY
- Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
- (2020) Guillermo Ruiz-Irastorza et al. RHEUMATOLOGY
- B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)
- (2020) Tamara Möckel et al. AUTOIMMUNITY REVIEWS
- An updated advance of autoantibodies in autoimmune diseases
- (2020) Ze Xiu Xiao et al. AUTOIMMUNITY REVIEWS
- Neuropsychiatric lupus: new mechanistic insights and future treatment directions
- (2019) Noa Schwartz et al. Nature Reviews Rheumatology
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients
- (2019) Matthias A. Cassia et al. Arthritis & Rheumatology
- New therapies for systemic lupus erythematosus — past imperfect, future tense
- (2019) Grainne Murphy et al. Nature Reviews Rheumatology
- Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies
- (2019) Xiaoyu Wang et al. Frontiers in Immunology
- BAFF inhibition in SLE-Is tolerance restored?
- (2019) Shaun W Jackson et al. IMMUNOLOGICAL REVIEWS
- Genetic contributors and soluble mediators in prediction of autoimmune comorbidity
- (2019) Adrianos Nezos et al. JOURNAL OF AUTOIMMUNITY
- Towards a pro-resolving concept in systemic lupus erythematosus
- (2019) Sebastian Boeltz et al. Seminars in Immunopathology
- Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
- (2019) Ignacio Sanz et al. Frontiers in Immunology
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
- (2018) Mario Mauthe et al. Autophagy
- Recent developments in biologic therapies for the treatment of patients with systemic lupus erythematosus
- (2018) Pedro L Carreira et al. RHEUMATOLOGY
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers
- (2018) Seyed Mostafa Monzavi et al. INFLAMMOPHARMACOLOGY
- Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
- (2018) Joan T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1
- (2018) Zev Sthoeger et al. CLINICAL IMMUNOLOGY
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2018) Scott A. Jenks et al. IMMUNITY
- The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting
- (2018) Laurie Baert et al. JOURNAL OF AUTOIMMUNITY
- Systemic lupus erythematosus: Diagnosis and clinical management
- (2018) Andrea Fava et al. JOURNAL OF AUTOIMMUNITY
- Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
- (2018) Rita Quelhas da Costa et al. JAMA Dermatology
- The deposition of anti-DNA IgG contributes to the development of cutaneous lupus erythematosus
- (2017) Yingying Dong et al. IMMUNOLOGY LETTERS
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
- (2017) Eoghan M McCarthy et al. RHEUMATOLOGY
- Immunoadsorption for collagen and rheumatic diseases
- (2017) Ken Yamaji TRANSFUSION AND APHERESIS SCIENCE
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus
- (2017) Yale Liu et al. Frontiers in Immunology
- Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8
- (2017) Pattarin Tangtanatakul et al. Scientific Reports
- Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review
- (2016) Andreas Kronbichler et al. AUTOIMMUNITY REVIEWS
- The features of skin inflammation induced by lupus serum
- (2016) Lena Liu et al. CLINICAL IMMUNOLOGY
- Overview of pathophysiology and treatment of human lupus nephritis
- (2016) Kimberly Trotter et al. CURRENT OPINION IN RHEUMATOLOGY
- Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies
- (2016) Sonya VanPatten et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE
- (2016) Aparna Mahajan et al. Frontiers in Immunology
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens
- (2015) Y. Xia et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms
- (2015) Markella Zannikou et al. IMMUNOLOGY
- Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus
- (2015) Juan P. Mackern-Oberti et al. IMMUNOLOGY
- Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase–DNA Interaction
- (2015) Jie An et al. JOURNAL OF IMMUNOLOGY
- TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus
- (2015) Jessica L. Doerner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-dsDNA antibodies induce inflammation via endoplasmic reticulum stress in human mesangial cells
- (2015) Hui Zhang et al. Journal of Translational Medicine
- Crosstalk between the cGAS DNA Sensor and Beclin-1 Autophagy Protein Shapes Innate Antimicrobial Immune Responses
- (2014) Qiming Liang et al. Cell Host & Microbe
- Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus
- (2014) William Stohl EXPERT OPINION ON THERAPEUTIC TARGETS
- Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus
- (2014) Zev Sthoeger et al. JOURNAL OF AUTOIMMUNITY
- pConsensus Peptide Induces Tolerogenic CD8+ T Cells in Lupus-Prone (NZB x NZW)F1 Mice by Differentially Regulating Foxp3 and PD1 Molecules
- (2014) R. P. Singh et al. JOURNAL OF IMMUNOLOGY
- Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes
- (2014) Menna R Clatworthy et al. NATURE MEDICINE
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Brutonˈs tyrosine kinase-an integral protein of B cell development that also has an essential role in the innate immune system
- (2013) Gabriela López-Herrera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)
- (2013) M Witt et al. LUPUS
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis
- (2012) Yumin Xia et al. CLINICAL IMMUNOLOGY
- Noncanonical Autophagy Is Required for Type I Interferon Secretion in Response to DNA-Immune Complexes
- (2012) Jill Henault et al. IMMUNITY
- The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies
- (2012) Yumin Xia et al. JOURNAL OF AUTOIMMUNITY
- The DWEYS peptide in systemic lupus erythematosus
- (2012) Xavier Bosch et al. TRENDS IN MOLECULAR MEDICINE
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?
- (2012) William Stohl Current Rheumatology Reports
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice
- (2011) Chaim O. Jacob et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice
- (2011) BJ Skaggs et al. LUPUS
- Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis
- (2011) JIANXIN LU et al. NEPHROLOGY
- Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity
- (2011) O. Bloom et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigen-specific immature dendritic cell vaccine ameliorates anti-dsDNA antibody-induced renal damage in a mouse model
- (2011) Y. Xia et al. RHEUMATOLOGY
- Regulation of the B Cell Receptor Repertoire and Self-Reactivity by BAFF
- (2010) M. Ota et al. JOURNAL OF IMMUNOLOGY
- Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus
- (2010) B. Diamond et al. JOURNAL OF INTERNAL MEDICINE
- Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms
- (2010) T. W. Faust et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide
- (2009) Smadar Lapter et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus
- (2009) Reshmi Parameswaran et al. CLINICAL IMMUNOLOGY
- TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells
- (2009) Hua-Xin Gao et al. CYTOKINE
- Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients
- (2008) Bevra H. Hahn et al. ARTHRITIS AND RHEUMATISM
- Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models
- (2008) Uri Sela et al. IMMUNOLOGY
- An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes
- (2008) Elisaveta Voynova et al. IMMUNOLOGY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now